Skip to main content
SpringerLink
Log in

Enrichment and detection of circulating tumor cells in peripheral blood

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Metastasis usually presents in the different courses of tumor diseases and associates with poor prognosis. Circulating tumor cells (CTC) are considered to be essential for conforming metastasis and can be detected in tumor patients’ peripheral blood. CTC are not easily detected by conventional cytology methods because of their low frequency in peripheral blood. Our article reviews the recent research results on this subject, and also discusses the problems and prospects in this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wittekind C, Neid M. Cancer invasion and metastasis. Oncology, 2005, 69: 14–16.

    Article  PubMed  Google Scholar 

  2. Dittmar T, Heyder C, Gloria-Maercker E, et al. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis, 2008, 25: 11–32.

    Article  PubMed  CAS  Google Scholar 

  3. Gertler R, Rosenberg R, Fuehrer K, et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res, 2003, 162: 149–155.

    PubMed  Google Scholar 

  4. Muller V, Stahmann N, Riethdorf S, et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res, 2005, 11: 3678–3685.

    Article  PubMed  Google Scholar 

  5. Zigeuner R E, Riesenberg R, Pohla H, et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol, 2003, 169: 701–705.

    Article  PubMed  CAS  Google Scholar 

  6. Chou T, Sano M, Ogura M, et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan. Breast Cancer, 2005, 12: 178–188.

    Article  PubMed  Google Scholar 

  7. Hu X C, Wang Y, Shi D R, et al. Immunomagnetic tumor cell enrichment is promising in detecting circulating breast cancer cells. Oncology, 2003, 64: 160–165.

    Article  PubMed  CAS  Google Scholar 

  8. Naume B, Borgen E, Tossvik S, et al. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Cytotherapy, 2004, 6: 244–252.

    Article  PubMed  CAS  Google Scholar 

  9. Talasaz A H, Powell A A, Huber D E, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A, 2009, 106: 3970–3975.

    Article  PubMed  CAS  Google Scholar 

  10. Deng G, Herrler M, Burgess D, et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res, 2008, 10: R69.

    Article  PubMed  Google Scholar 

  11. Borgen E, Pantel K, Schlimok G, et al. A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin Cytom, 2006, 70: 400–409.

    CAS  Google Scholar 

  12. Saloustros E, Mavroudis D. Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis. Future Oncol, 2010, 6: 209–219.

    Article  PubMed  CAS  Google Scholar 

  13. Wong SC, Chan CM, Ma BB, et al. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res, 2009, 15: 1005–1012.

    Article  PubMed  CAS  Google Scholar 

  14. Cohen SJ, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer, 2006, 6: 125–132.

    Article  PubMed  CAS  Google Scholar 

  15. Hsieh HB, Marrinucci D, Bethel K, et al. High speed detection of circulating tumor cells. Biosens Bioelectron, 2006, 21: 1893–1899.

    Article  PubMed  CAS  Google Scholar 

  16. Gerges N, Rak J, Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull, 2010, 94: 49–64.

    Article  PubMed  Google Scholar 

  17. Goodale D, Phay C, Postenka CO, et al. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry A, 2009, 75: 344–355.

    PubMed  Google Scholar 

  18. Hoffmann AC, Warnecke-Eberz U, Luebke T, et al. Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol, 2007, 95: 51–54.

    Article  PubMed  CAS  Google Scholar 

  19. Schmitt M, Foekens JA. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells. Breast Cancer Res, 2009, 11: 109.

    Article  PubMed  Google Scholar 

  20. Riethdorf S, Fritsche H, Muller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res, 2007, 13: 920–928.

    Article  PubMed  CAS  Google Scholar 

  21. Balic M, Dandachi N, Hofmann G, et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom, 2005, 68: 25–30.

    PubMed  Google Scholar 

  22. Alix-Panabieres C, Brouillet J P, Fabbro M, et al. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. J Immunol Methods, 2005, 299: 177–188.

    Article  PubMed  CAS  Google Scholar 

  23. Alix-Panabieres C, Vendrell JP, Pelle O, et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem, 2007, 53: 537–539.

    Article  PubMed  CAS  Google Scholar 

  24. Alix-Panabieres C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res, 2008, 14: 5013–5021.

    Article  PubMed  CAS  Google Scholar 

  25. Uhr J W. Cancer diagnostics: one-stop shop. Nature, 2007, 450: 1168–1169.

    Article  PubMed  CAS  Google Scholar 

  26. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature, 2007, 450: 1235–1239.

    Article  PubMed  CAS  Google Scholar 

  27. Maheswaran S, Sequist L V, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med, 2008, 359: 366–377.

    Article  PubMed  CAS  Google Scholar 

  28. Botteri E, Sandri M T, Bagnardi V, et al. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat, 2010, 122: 211–217.

    Article  PubMed  CAS  Google Scholar 

  29. Daskalaki A, Agelaki S, Perraki M, et al. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. Br J Cancer, 2009, 101: 589–597.

    Article  PubMed  CAS  Google Scholar 

  30. Marrinucci D, Bethel K, Luttgen M, et al. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med, 2009, 133: 1468–1471.

    PubMed  Google Scholar 

  31. Bevilacqua S, Gallo M, Franco R, et al. A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer, 2009, 65: 123–125.

    Article  PubMed  Google Scholar 

  32. Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 2008, 26: 3213–3221.

    Article  PubMed  Google Scholar 

  33. Cohen SJ, Punt CJ, Iannotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol, 2009, 20: 1223–1229.

    Article  PubMed  CAS  Google Scholar 

  34. Okegawa T, Nutahara K, Higashihara E. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol, 2009, 181: 1091–1097.

    Article  PubMed  Google Scholar 

  35. Okegawa T, Nutahara K, Higashihara E. Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Int J Urol, 2010, 17: 466–475.

    Article  PubMed  CAS  Google Scholar 

  36. Bluemke K, Bilkenroth U, Meye A, et al. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev, 2009, 18: 2190–2194.

    Article  PubMed  CAS  Google Scholar 

  37. Soria JC, Morat L, Durdux C, et al. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity. J Urol, 2002, 167: 352–356.

    Article  PubMed  CAS  Google Scholar 

  38. Gradilone A, Petracca A, Nicolazzo C, et al. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int, 2010, 106: 710–715.

    Article  PubMed  CAS  Google Scholar 

  39. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol, 2008, 15: 3092–3100.

    Article  PubMed  Google Scholar 

  40. Hoffmann A C, Vallbohmer D, Prenzel K, et al. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol, 2009, 135: 1231–1237.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi’an, 710038, China

    Weifeng Jiang & Helong Zhang

Authors
  1. Weifeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helong Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, W., Zhang, H. Enrichment and detection of circulating tumor cells in peripheral blood. Chin. -Ger. J. Clin. Oncol. 10, 240–244 (2011). https://doi.org/10.1007/s10330-011-0768-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-011-0768-9

Key words

Search

Navigation